ARTICLE
14 December 2020

HHS Announces Formation Of FCA Working Group

On December 4, 2020, the US Department of Health and Human Services (HHS) announced that it is creating a False Claims Act Working Group to enhance the partnership between DOJ and the...
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On December 4, 2020, the US Department of Health and Human Services (HHS) announced that it is creating a False Claims Act Working Group to enhance the partnership between DOJ and the HHS Office of Inspector General (OIG) in combatting fraud and abuse. The purpose of the Working Group is to focus resources on identifying those who seek to defraud American taxpayers. HHS administers trillions of dollars in grants and other payments to public and private recipients annually. As the agency administering those funds, HHS is in a unique position to assist DOJ in identifying and evaluating potential fraud.

The Working Group is comprised of former DOJ False Claims Act and healthcare fraud prosecutors, former private attorneys for healthcare and life sciences companies, and HHS attorneys. In addition to identifying and referring fraudulent activity to DOJ and OIG, the Working Group will provide expertise on the complex legal framework of the numerous HHS funding programs. The Working Group will also provide targeted training to the attorneys and HHS program operators on HHS programs that are most susceptible to fraud and abuse.

"Fraud on the federal government is not a victimless crime. Every dollar that goes to fraudsters is a dollar not being used for the important work that HHS programs do for the American people, including to fight COVID-19," said HHS Secretary Alex Azar. "This working group strengthens our partnership with DOJ and OIG on using the False Claims Act to pursue bad actors and protect taxpayer funds. Ensuring that resources are focused on bad actors will deter would-be fraudsters and avoid burdening those working in good faith to comply with the law."

The HHS press release is here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

ARTICLE
14 December 2020

HHS Announces Formation Of FCA Working Group

United States Food, Drugs, Healthcare, Life Sciences

Contributor

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More